Event Type
Disclosure
Mandatory
Variant
8-K
Costs Associated with Exit or Disposal Activities. On September 30, 2025, the Board of Directors of Applied DNA Sciences, Inc. (the “ Company ”) authorized, and
, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of
Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Press Release, dated October 6, 2025. 104 Cover Page Interactive Data File (embed